Summary
There has been increasing evidence which suggests that abnormal expression of the estrogen receptor (ER) protein in nonmalignant breast tissue may be important in the carcinogenic process. To examine the effects of ER expression in immortalized nonmalignant mammary epithelial cells, an expression vector containing human ER cDNA was transfected into the ER negative human breast cells, MCF10A. Characterization of a clone stably expressing ER, 139B6, provided evidence for the regulated synthesis of a functional ER capable of binding estradiol-17β (E2) and undergoing processing. Expression of the ER gene did not enable E2 to stimulate endogenous genes [progesterone receptor (PgR), pS2, cathepsin D and TGFα] which normally respond to estrogens in breast cancer cells. The ER in 139B6 cells was, however, capable of inducing expression of an ERE-regulated reporter gene, indicating its ability to interact with transcriptional machinery. Furthermore, cultures in log growth displayed a slight increase in doubling time in the presence of E2. These results indicate that ER expression alone is not sufficient to induce a transformed phenotype. Thus, the 139B6 cell line should provide a new model for determining what additional changes lead to increased growth potential in response to E2 and for exploring how E2 itself may help bring about changes leading to progression of preneoplastic breast epithelial cells.
References
Beatson GT: On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet ii: 104–107, 1896
Zajchowski DA, Sager R, Webster L: Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant receptor. Cancer Res 53: 5004–5011, 1993
Brooks SC, Pauley R: Breast Cancer Biology. In: Dulbecco R (ed) Encyclopedia of Human Biology, vol 2. Academic Press Inc, San Diego, 1991, pp 53–65
Peterson OW, Hoyer PE, VanDeurs B: Frequence and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 47: 5748–5751, 1987
Khan SA, Rogers MAM, Obando JA, Tamsen A: Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 54: 993–997, 1994
Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends in Genetics 9: 138–141, 1993
Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759–767, 1990
Bartek J, Bartkova J, Kyprianou N, Lalani E-N, Staskova Z, Shearer M, Chang S, Taylor-Papadimitriou J: Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of Simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci USA 88: 3520–3524, 1991
Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF10. Cancer Res 50: 6075–6086, 1990
Briand P, Peterson OW, van Deurs B: A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined media.In vitro Cell Dev Biol 23: 181–188, 1987
Caron de Fromentel C, Nardeux PC, Soressi T, Lavialle C, Estrade S, Carloni G, Chandrasekaran K, Carsingena R: Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbors SV40 genetic information. Exp Cell Res 16: 83–94, 1985
Stampfer MR, Bartley JC: Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc Natl Acad Sci USA 82: 2394–2398, 1985
Chang SE, Keen J, Lane EB, Taylor-Papadimitriou J: Establishment and characterization of SV40-transformed breast epithelial cell lines. Cancer Res 42: 2040–2053, 1982
Gaffney EV: A cell line (HBL-100) established from breast milk. Cell Tissue Res 227: 563–568, 1982
Hackett AJ, Smith HS, Springer EL, Owens RB, Nelson Rees NA, Riggs JL, Gardner MB: Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst 58: 1795–1806, 1977
Berry M, Metzger D, Chambon P: Role of the two activation domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9: 2811–2818, 1990
Metzger D, White JH, Chambon P: The human estrogen receptor functions in yeast. Nature 334: 31–36, 1988
Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J: Sequence and expression of human estrogen receptor complementary DNA. Science 231: 1150–1154, 1986
Kushner PJ, Hort E, Shine J, Baxter JD, Greene GL: Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol Endocrinol 4: 1465–1473, 1990
Touitou I, Mathieu M, Rochefort H: Stable transfection of the estrogen receptor cDNA into HeLa cells induces estrogen responsiveness of endogenous cathepsin D gene but not of cell growth. Biochem Biophys Res Commun 169: 109–115, 1990
Sadovsky Y, Kushner PJ, Roberts JM, Riemer RK: Restoration of estrogen-dependent progesterone receptor expression in a uterine myocyte cell line. Endocrinology 132: 1609–1613, 1993
Migliaccio S, Davis VL, Gibson MK, Gray TK, Korach KS: Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor. Endocrinology 130: 2617–2624, 1992
Jiang SY, Jordan VC: Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst 8: 580–591, 1992
Zajchowski DA, Sager R: Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor. Mol Endocrinol 5: 1613–1623, 1991
Wiese TE, Kral LG, Dennis KE, Butler WB, Brooks SC: Optimization of estrogen growth response in MCF-7 cells.In vitro Cell Dev Biol 28A: 595–602, 1992
Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, Chambon P: The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8: 1981–1986, 1989
Gunning P, Leavitt J, Muscat G, Ng S-Y, Kedes L: A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci USA 84: 4831–4835, 1987
Green S, Issemann I, Sheer E: A versatilein vivo andin vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res 16: 369, 1988
Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd edition, Cold Spring Harbor Laboratory Press, 1989
Ausubel FM, Brent R, Kingston RE, More DM, Smith JA, Seidman JG, Struhl K (eds) Current Protocols in Molecular Biology. Greene Publishing Associates and Wiley Interscience, New York, 1987
Davis MD, Butler WB, Brooks SC: Induction of tissue plasminogen activator mRNA and activity by structurally altered estrogens. J Steroid Biochem Mol Biol 52: 421–430, 1995
Pilat MJ, Hafner MS, Kral LG, Brooks SC: Differential induction of pS2 and cathepsin D mRNAs by structurally altered estrogens. Biochemistry 32: 7009–7015, 1993
Davies IJ, Naftolin F, Ryan KJ, Fishman J, Siu J: The affinity of catechol estrogens for estrogen receptors in the pituitary and anterior hypothalamus of the rat. Endocrinology 97: 554–557, 1975
Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–672, 1949
Vander Kuur JA, Wiese T, Brooks SC: Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex. Biochemistry 32: 7002–7008, 1993
Kral L, Doherty LM, Brooks SC: Quantitative determination of nuclear estrogen receptors by an enzyme immunoassay: applications and caveats. J Steroid Biochem 31: 459–466, 1988
Burton KA: A study of conditions and mechanism of diphenylamine reaction for the colormetric estimation of deoxyribonucleic acid. Biochem J 62: 315–322, 1956
Butler WB: Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle. Anal Biochem 141: 70–73, 1984
Brash DE, Reddel RR, Quanrud M, Yang K, Farrell MP, Harris CC: Strontium phosphate transfection of human cells in primary culture: stable expression of the Simian virus 40 large T-antigen gene in primary human bronchial epithelial cells. Mol Cell Biol 7: 2031–2034, 1987
VanderKuur JA, Hafner MS, Christman JK, Brooks SC: Effects of estradiol-17β analogues on activation of estrogen responsive element regulated chloramphenicol acetyltransferase expression. Biochemistry 32: 7016–7021, 1993
Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2: 1044–1049, 1982
Gyling M, Leclercq G: Estrogen and antiestrogen interaction with estrogen receptor of MCF7 cells — relationship between processing and estrogenicity. J Steroid Biochem 29: 1–8, 1988
Saceda M, Lippman ME, Chambon P, Lindsey RL, Ponglikitmongkol M, Puente M, Martin MB: Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2: 1157–1162, 1988
Brooks SC, Hansen ER, Saunders DE, Battelli MG, Shafie SM: Effect of growth on the estrogen receptor levels in MCF-7 cells. Cancer Res 44: 3724–3729, 1984
Horwitz KB, McGuire WL: Estrogen control of progesterone receptor in human breast cancer: correlation with nuclear processing of estrogen receptor. J Biol Chem 253: 2223–2228, 1978
Danilition SL, Frederickson RM, Taylor CY, Miyamoto NG: Transcription factor binding and spacing constraints in the human beta-actin proximal promoter. Nucleic Acids Res 19: 6913–6922, 1991
Morishita H, Nakamura N, Yamakawa T, Ogino H, Kanamori T, Nobuhara M, Namba M: Stable expression of human tissue-type plasminogen activator regulated by beta-actin promoter in three human cell lines: HeLa, WI-38 VA13, and KMS-5. Biochim Biophys Acta 1090: 216–222, 1991
Rhode PR, Gorski J: Growth and cell cycle regulation of mRNA levels in GH3 cells. Mol Cell Endocrinol 82: 11–22, 1991
Greenberg ME, Ziff EB: Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311: 433–438, 1984
Zajchowski DA, Band V, Trask DK, Kling D, Connolly JL, Sager R: Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells. Proc Natl Acad Sci USA 87: 2314–2319, 1990
Cavailles V, Garcia M, Rochefort H: Regulation of the cathepsin D and pS2 gene expression by growth factors in MCF-7 human breast cancer cells. Mol Endocrinol 3: 552–558, 1989
May FEB, Westley BR: Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells. Cancer Res 46: 6034–6040, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pilat, M.J., Christman, J.K. & Brooks, S.C. Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6. Breast Cancer Res Tr 37, 253–266 (1996). https://doi.org/10.1007/BF01806507
Issue Date:
DOI: https://doi.org/10.1007/BF01806507